Editorial comment on: histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.
Haferkamp
Axel
A
D000283:Administration, Intravesical; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D009465:Neuromuscular Agents / Q000008:administration & dosage* / Q000494:pharmacology; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy* / Q000473:pathology*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000473:pathology*; D019459:Urothelium / Q000187:drug effects / Q000473:pathology
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A